We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTB
1326
DELISTED
Cooper Tire & Rubber Co.
CTB
| $39K | ﹤0.01% |
+972
| New | +$37.1K |
|
1327
Conduent
CNDT
$276M
| $38K | ﹤0.01% |
+8,110
| New | +$33.9K |
|
1328
Cohu
COHU
$2.52B
| $38K | ﹤0.01% |
+996
| New | +$27.2K |
|
1329
Cytosorbents Corp
CTSO
$23.9M
| $38K | ﹤0.01% |
+4,829
| New | +$40.4K |
|
1330
Lightspeed Commerce
LSPD
$1.36B
| $38K | ﹤0.01% |
+545
| New | +$25.2K |
|
1331
Mercury Insurance
MCY
$5.94B
| $38K | ﹤0.01% |
737
-186
| -20% | -$8.32K |
|
1332
NNN REIT
NNN
$9.02B
| $38K | ﹤0.01% |
942
-658
| -41% | -$24.8K |
|
|
CORE
1333
DELISTED
Core Mark Holding Co., Inc.
CORE
| $38K | ﹤0.01% |
1,305
| – | – |
|
1334
American Public Education
APEI
$967M
| $37K | ﹤0.01% |
1,230
-1,490
| -55% | -$45.8K |
|
1335
B&G Foods
BGS
$280M
| $37K | ﹤0.01% |
+1,336
| New | +$37.7K |
|
|
CSW
1336
CSW Industrials
CSW
$5.74B
| $37K | ﹤0.01% |
+339
| New | +$33.8K |
|
1337
Globus Medical
GMED
$11.1B
| $37K | ﹤0.01% |
573
| – | – |
|
1338
Liberty Broadband Class C
LBRDK
$5.18B
| $37K | ﹤0.01% |
238
-8
| -3% | -$1.22K |
|
1339
Nature's Sunshine
NATR
$288M
| $37K | ﹤0.01% |
+2,501
| New | +$30.9K |
|
1340
Steven Madden
SHOO
$3.57B
| $37K | ﹤0.01% |
1,074
-184
| -15% | -$5.23K |
|
1341
Tompkins Financial
TMP
$1.41B
| $37K | ﹤0.01% |
537
+433
| +416% | +$27.4K |
|
|
BMCH
1342
DELISTED
BMC Stock Holdings, Inc
BMCH
| $37K | ﹤0.01% |
+700
| New | +$32.4K |
|
|
VER
1343
DELISTED
VEREIT, Inc.
VER
| $37K | ﹤0.01% |
982
-737
| -43% | -$26.2K |
|
|
MNR
1344
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $37K | ﹤0.01% |
+2,153
| New | +$32.5K |
|
1345
Adecoagro
AGRO
$1.37B
| $36K | ﹤0.01% |
5,325
+762
| +17% | +$4.21K |
|
1346
Ameresco
AMRC
$1.37B
| $36K | ﹤0.01% |
+704
| New | +$30.3K |
|
1347
CorVel
CRVL
$3.23B
| $36K | ﹤0.01% |
1,047
-1,476
| -59% | -$45.8K |
|
1348
Essex Property Trust
ESS
$18.4B
| $36K | ﹤0.01% |
152
-264
| -63% | -$60.9K |
|
1349
Farmers National Banc Corp
FMNB
$935M
| $36K | ﹤0.01% |
2,784
| – | – |
|
1350
Plexus
PLXS
$7.23B
| $36K | ﹤0.01% |
472
-9,044
| -95% | -$675K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.